Grade 3 Follicular Lymphoma
5 clinical trials · Condition
◉ Watch Grade 3 Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma (NCT02702141) | Seagen Inc. | 2016-02-01 |
| Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715) | Mayo Clinic | 2016-01-19 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (NCT01484015) | Wake Forest University Health Sciences | 2011-02-01 |
| Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma (NCT01239875) | Mayo Clinic | 2010-11-01 |
| Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma (NCT01000753) | Children's Oncology Group | 2005-05-30 |
Track Grade 3 Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.